Bio-identical Hormone Replacement Therapy (BHRT)
These products are compounded to an individual prescription from your doctor. Although the active constituents are pharmaceutical USP grade bioidentical hormones, the preparations are not individually TGA approved. Some large cohort studies including the French E3N study, have been conducted on patients using compounded bioidentical hormones and these studies have contributed to the development and controlled trials of set dose products that have been listed on the TGA register. However, because each prescription is compounded for an individual’s needs, there is no data available from controlled studies on these specific preparations regarding efficacy and safety.
Compounded bioidentical hormones may provide an option for patients where a commercial/pharmaceutical product does not achieve the desired therapeutic outcomes for patients and an alternate strength or mode of application, which is not commercially available, is indicated.